Clinical Study to Evaluate the Bioequivalence of Two Imiquimod Cream 3.75% Formulations in Patients With Actinic Keratosis.

NCT01788007 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

443

Enrollment

INDUSTRY

Sponsor class

Conditions

Actinic Keratosis

Interventions

DRUG: Imiquimod Topical Cream 3.75%
DRUG: Zyclara® (imiquimod) Topical Cream 3.75%
DRUG: Vehicle Topical Cream

Sponsor

Sun Pharmaceutical Industries, Inc.